Stay updated on Nivolumab in Malignant Pleural Mesothelioma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Malignant Pleural Mesothelioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Malignant Pleural Mesothelioma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The clinical trial record for the nivolumab and nivolumab-plus-ipilimumab study in unresectable malignant pleural mesothelioma is displayed, with its study details, eligibility criteria, locations, and outcome measures.
    Difference
    52%
    Check dated 2026-11-09T23:28:01.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer now identifies the ClinicalTrials.gov site revision as v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-11-02T23:27:14.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces updates and FAQs about a transition in terminology from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-26T23:18:03.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The site revision label in the footer changes from v3.7.1 to v3.7.2 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-19T23:29:54.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-13T05:43:28.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study content and navigation with a basic header/footer. Most detailed study information and links are no longer accessible on this page.
    Difference
    17%
    Check dated 2026-09-21T23:46:46.000Z thumbnail image

Stay in the know with updates to Nivolumab in Malignant Pleural Mesothelioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Malignant Pleural Mesothelioma Clinical Trial page.